DK163181C - Analogifremgangsmaade til fremstilling af n,n'-di(arylalkylen)alkylendiaminer eller farmaceutisk acceptable salte deraf - Google Patents

Analogifremgangsmaade til fremstilling af n,n'-di(arylalkylen)alkylendiaminer eller farmaceutisk acceptable salte deraf

Info

Publication number
DK163181C
DK163181C DK349582A DK349582A DK163181C DK 163181 C DK163181 C DK 163181C DK 349582 A DK349582 A DK 349582A DK 349582 A DK349582 A DK 349582A DK 163181 C DK163181 C DK 163181C
Authority
DK
Denmark
Prior art keywords
alkylendiamin
arylalkylene
analogue
preparation
acceptable salts
Prior art date
Application number
DK349582A
Other languages
English (en)
Other versions
DK349582A (da
DK163181B (da
Inventor
John Bates Farmer
Francis Ince
Rodney Alan Brown
John Dixon
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of DK349582A publication Critical patent/DK349582A/da
Publication of DK163181B publication Critical patent/DK163181B/da
Application granted granted Critical
Publication of DK163181C publication Critical patent/DK163181C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK349582A 1981-08-05 1982-08-04 Analogifremgangsmaade til fremstilling af n,n'-di(arylalkylen)alkylendiaminer eller farmaceutisk acceptable salte deraf DK163181C (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB8123962 1981-08-05
GB8123962 1981-08-05
GB8130594 1981-10-09
GB8130595 1981-10-09
GB8130595 1981-10-09
GB8130594 1981-10-09
GB8134551 1981-11-17
GB8134551 1981-11-17

Publications (3)

Publication Number Publication Date
DK349582A DK349582A (da) 1983-02-06
DK163181B DK163181B (da) 1992-02-03
DK163181C true DK163181C (da) 1992-06-22

Family

ID=27449264

Family Applications (1)

Application Number Title Priority Date Filing Date
DK349582A DK163181C (da) 1981-08-05 1982-08-04 Analogifremgangsmaade til fremstilling af n,n'-di(arylalkylen)alkylendiaminer eller farmaceutisk acceptable salte deraf

Country Status (20)

Country Link
US (1) US5013760A (da)
EP (1) EP0072061B1 (da)
AU (1) AU538078B2 (da)
CA (1) CA1191846A (da)
CY (1) CY1428A (da)
DE (1) DE3263531D1 (da)
DK (1) DK163181C (da)
ES (1) ES514725A0 (da)
FI (1) FI82238C (da)
GR (1) GR77995B (da)
HK (1) HK41388A (da)
IE (1) IE53827B1 (da)
IL (1) IL66449A (da)
LU (1) LU88284I2 (da)
MY (1) MY8700459A (da)
NL (1) NL930078I2 (da)
NO (1) NO154492C (da)
NZ (1) NZ201479A (da)
PT (1) PT75380B (da)
SG (1) SG46287G (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8301754D0 (en) * 1983-01-21 1983-02-23 Fisons Plc Formulation
FI843507L (fi) * 1983-01-21 1984-09-07 Fisons Plc Aromatiska aminer.
EP0375668A3 (en) * 1983-10-25 1990-10-17 FISONS plc Phenylethylamines, process for their preparation and compositions containing them
US4720586A (en) * 1983-12-06 1988-01-19 Fisons, Plc Substituted 3,4-dihydroxy-phenylethylamino compounds
AU587217B2 (en) * 1985-01-15 1989-08-10 Glaxo Group Limited Amine derivatives
DE3679784D1 (de) * 1985-11-20 1991-07-18 Fisons Plc Catecholamin-derivate, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen.
GB8603765D0 (en) * 1986-02-15 1986-03-19 Beecham Wuelfung Gmbh & Co Kg Compounds
US5602174A (en) * 1986-02-15 1997-02-11 Beecham Wuefling Gmbh & Co. Treatment
GB2192394A (en) * 1986-07-11 1988-01-13 Glaxo Group Ltd Amine derivatives
US5753714A (en) * 1987-02-03 1998-05-19 Merrell Pharmaceuticals Inc. Polyamine derivatives
DE3874206D1 (de) * 1987-05-19 1992-10-08 Fisons Plc 2-(3-4-dihydroxyphenyl)-aethylamine, ihre herstellung und ihre verwendung als arzneimittel.
IT1254521B (it) * 1992-03-17 1995-09-25 Zambon Spa Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare
IT1271411B (it) * 1993-09-14 1997-05-28 Zambon Spa Derivati del 2-ammino-1,2,3,4-tetraidro-naftalene attivi sul sistema cardiovascolare
IT1271007B (it) * 1994-09-13 1997-05-26 Zambon Spa Derivati del 2-ammino-1,2,3,4-tetraidronaftalene attivi sul sistema cardiovascolare
IT1271008B (it) * 1994-09-13 1997-05-26 Zambon Spa Derivati del 2-ammino-1,2,3,4-tetraidro-naftalene attivi sul sistema cardiovascolare
FR2870537A1 (fr) * 2004-05-19 2005-11-25 Servier Lab Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
AU2009308462B2 (en) 2008-10-21 2015-06-11 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Animal model for evaluating vasomotor response in vivo
CN105001103B (zh) * 2015-05-31 2017-11-03 江苏同禾药业有限公司 一种盐酸多培沙明中间体的合成方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2653977A (en) * 1953-09-29 Chxnx
US2739981A (en) * 1952-08-26 1956-03-27 American Home Prod Diamines and salts thereof
US2937185A (en) * 1956-08-13 1960-05-17 Lakeside Lab Inc Diamino alkanols and alkanones
US3013020A (en) * 1958-01-24 1961-12-12 Miles Lab N,n'-bis-phenyl-alkylene-diamines
GB1004071A (en) * 1961-07-03 1965-09-08 Council Scient Ind Res Substituted ª‰-phenethylamines and a process for the production thereof
GB1025699A (en) * 1965-01-08 1966-04-14 Boehringer & Soehne Gmbh New n,n-diphenyl-alkylene-ª‡,ªÏ-diamines
DE1768297B1 (de) * 1968-04-26 1971-12-16 Beiersdorf Ag Substituierte Alkylendiamine und deren Salze
US3867454A (en) * 1971-03-10 1975-02-18 Sterling Drug Inc 1,1-BRIDGED-BIS(N-aralkyl-2-aminoethanols)
US3933913A (en) * 1971-06-01 1976-01-20 Smithkline Corporation N,N'-bis[3-substituted-4-hydroxypheyl)-2-hydroxyethyl)]-polymethylenediamines
GB1440440A (en) * 1972-10-06 1976-06-23 Manuf Prod Pharma Tetrahydronaphthalene derivatives
DK449974A (da) * 1973-08-31 1975-04-28 Sandoz Ag
US3928323A (en) * 1973-12-18 1975-12-23 Millmaster Onyx Corp Anti-microbial quaternary ammonium co-polymers
US3960959A (en) * 1973-12-19 1976-06-01 Sandoz Ltd. N,N'-bis{6-[(3,4-dihydroxyphenyl)alkylamino]-hexyl}hexamethylenediamines and the salts thereof
US4210749A (en) * 1974-11-12 1980-07-01 Pennwalt Corporation Substituted 1,2,4,5-tetrahydro-3H,3 benzazepines
US4163063A (en) * 1976-01-02 1979-07-31 University Of Iowa Research Foundation Aminotetralin adrenergic β-agonists
GB8301754D0 (en) * 1983-01-21 1983-02-23 Fisons Plc Formulation

Also Published As

Publication number Publication date
FI822630A0 (fi) 1982-07-28
DK349582A (da) 1983-02-06
CA1191846A (en) 1985-08-13
FI82238B (fi) 1990-10-31
PT75380B (en) 1986-02-12
AU538078B2 (en) 1984-07-26
FI82238C (fi) 1991-02-11
IE53827B1 (en) 1989-03-15
NL930078I2 (nl) 1993-11-16
NO822671L (no) 1983-02-07
NO154492B (no) 1986-06-23
IL66449A0 (en) 1982-12-31
EP0072061B1 (en) 1985-05-15
MY8700459A (en) 1987-12-31
IE821872L (en) 1983-02-05
LU88284I2 (fr) 1994-05-04
CY1428A (en) 1988-09-02
ES8405757A1 (es) 1984-06-16
EP0072061A1 (en) 1983-02-16
GR77995B (da) 1984-09-26
NL930078I1 (nl) 1993-09-16
NO154492C (no) 1986-10-01
AU8670282A (en) 1983-02-10
ES514725A0 (es) 1984-06-16
US5013760A (en) 1991-05-07
DK163181B (da) 1992-02-03
HK41388A (en) 1988-06-10
NZ201479A (en) 1986-07-11
DE3263531D1 (en) 1985-06-20
FI822630L (fi) 1983-02-06
IL66449A (en) 1986-12-31
SG46287G (en) 1987-11-13
PT75380A (en) 1982-09-01

Similar Documents

Publication Publication Date Title
DK149308C (da) Analogifremgangs-maade til fremstilling af trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater eller farmaceutisk acceptablesyreadditionssalte deraf
DK161770C (da) Analogifremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf
DK159117C (da) Fremgangsmaade til fremstilling af de rene enkeltfaktorer 1, 2, 3, 4 og 5 af teichomycin a2 eller farmaceutisk acceptable salte deraf
DK161968C (da) Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf
DK148537C (da) Analogifremgangsmaade til fremstilling af 3-aminopyridazinforbindelser eller farmaceutisk acceptable salte deraf
DK151017C (da) Analogifremgangsmaade til fremstilling af substituerede n-(4-indolyl-piperidino-alkyl)-benzimidazoloner eller fysiologisk acceptable syreadditionssalte deraf
DK157862C (da) Analogifremgangsmaade til fremstilling af imidazolylphenylamidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK149856C (da) Fremgangsmaade til fremstilling af 1,3-di- eller 1,3,8-trisubstituerede xanthiner eller fysiologisk acceptable salte deraf
DK162842C (da) Analogifremgangsmaade til fremstilling af 1-perfluoralkyl-2-(1,2,4-triazol-1-yl)-ethanol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK162166C (da) Analogifremgangsmaade til fremstilling af (2s)-isomere af 2-oe4-(2-hydroxycyclopentan-1-ylmethyl)phenylaapropionsyre eller farmaceutisk acceptable salte deraf
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK159853C (da) Analogifremgangsmaade til fremstilling af 9-dihydro-11,12-o-isopropyliden-erythromycin a eller -4ae-epi-erythromycin a eller 2'-o-acylater deraf eller farmaceutisk acceptable syreadditionssalte deraf
DK151805C (da) Analogifremgangsmaade til fremstilling af 20,21-di-nor-eburnameninderivater eller farmaceutisk acceptable additionssalte deraf
DK150597C (da) Analogifremgangsmaade til fremstilling af 3,4-bis-substituerede 1,2,5-oxadiazol-2-oxider eller farmakologisk acceptable syreadditionssalte deraf
DK157135C (da) Analogifremgangsmaade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK157451C (da) Analogifremgangsmaade til fremstilling af 2,4-diamino-6-alkoxybenzyl-5-methylpyridooe2,3-daapyrimidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK152115C (da) Analogifremgangsmaade til fremstilling af fluorerede 2,5-diamino-3-pentenderivater og farmaceutisk acceptable salte deraf
DK160875C (da) Analogifremgangsmaade til fremstilling af 3,7-diazabicyklooe3.3.1aa-nonanforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK165005C (da) Analogifremgangsmaade til fremstilling af 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater eller terapeutisk acceptable salte deraf
DK158227C (da) Analogifremgangsmaade til fremstilling af substituerede imidazooe1,5-aaapyridiner eller 5,6,7,8-tetrahydroderivater deraf eller salte deraf
DK157023C (da) Analogifremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
DK152491C (da) Analogifremgangsmaade til fremstilling af esterholdige phenoxypropanolaminer eller farmaceutisk anvendelige salte deraf
DK157021C (da) Analogifremgangsmaade til fremstilling af 2,3-polymethylen-4-oxo-4h-pyrido- eller -azepinooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf
DK150481C (da) Analogifremgangsmaade til fremstilling af 3',4'-dihydro-spiro-(imidazolidin-4,1'-(2'h)-naphthalen)-5-on eller farmaceutisk acceptable syreadditionssalte deraf
DK151021C (da) Analogifremgangsmaade til fremstilling af 17,18-dehydro-apovincaminol-3',4',5'-trimethoxybenzoat eller farmaceutisk acceptable syreadditionssalte deraf